Skip to content

tDCS and Speech Therapy to Improve Aphasia

MP-LoGa: Bi-hemispheral Transcranial Direct Current Stimulation to Improve the Severe Aphasia in Subacute Stroke Patients: a Randomized, Placebo-controlled, Double Blinded Multi-center Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02395874
Acronym
MP-LOGA
Enrollment
96
Registered
2015-03-24
Start date
2015-05-31
Completion date
2018-10-31
Last updated
2016-09-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aphasia, Global, Speech Therapy, Stroke, Transcranial Direct Current Stimulation

Brief summary

To study the effect of combined tDCS plus speech therapy compared to sham-tDCS plus speech therapy in subacute stroke patients suffering from moderate or severe aphasia. The patients will be randomized by a computer-generated lot. Assessment will be performed at study onset, after six weeks at the end of the specific intervention and 4 months after stroke onset for follow-up.

Detailed description

Approximately 25% of all patients after stroke suffer from aphasia. The aphasia could be so severe, that the patient cannot produce any words at all, and so the communication ability is rather poor. In that case speech therapy is the most common therapy, but the functional outcome for the patient is often not sufficiently. The transcranial direct current stimulation (tDCS) might improve the outcome of speech therapy in patients with severe aphasia. The patients will be randomized either to verum stimulation (group A) or sham stimulation (group B). In group A they will receive every workday for 6 weeks 20min of tDCS with 2 mA in combination with a 30 min speech therapy. In group B they will receive every workday for 6 weeks 20min of tDCS with 0 mA in combination with a 30 min speech therapy. The anodal electrode will be placed in case of a total anterior circulation stroke on the homologous speech area on the right hemisphere and in case of a partial anterior circulation stroke perilesional on the left hemisphere. The cathode will be positioned contralateral.

Interventions

PROCEDUREtDCS + speech therapy

Patients either receive 20min of tDCS with 2mA + speech therapy every work for 6 weeks. The anodal electrode will be placed either on the homologous speech area (TACS) in the right hemisphere or on the speech area perilesional in the left hemisphere (PACS). The cathodal electrode will be placed contralateral. Patients in group B will follow the same protocol, except for the stimulation intensity (2 mA versus 0 mA) the speech therapist will apply the tdcs according to the protocol. The tdcs machine is out of sight of the patient, so that she/he does not see, whether the machine is switched on or not. In case of sham stimulation the device will be switched on very slowly for the first 20 s and will than be set back to 0mA within the following 10 s. So that the patient will feel also the characteristic tingling under the electrodes.

Sponsors

Medical Park AG
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* first time stroke (ischemic or hemorrhagic), either with a total or partial anterior circulation stroke according to the Bamford classification * stroke interval 10-45 days * moderate or severe aphasia, i.e. Goodglass-Kaplan-Communication-Scale (GKS, 0,1 or 2) * native speaker - german * age 18-90

Exclusion criteria

* other neurological diseases affecting the CNS * known history of epileptic fits, except for an immediate fit * signs in the EEG of increased cortical excitability * patients with hemicraniectomy * fluent aphasia, i.e. GKS 3,4 or 5 * speech apraxia * reduced sensibility of the scalp * previously radiated scalp * metallic parts or implants in the brain * participation in other interventional studies

Design outcomes

Primary

MeasureTime frameDescription
Goodglass-Kaplan communication scale (GKS, 0-5)10-15 minthe GKS is an ordinal scale, which assesses the communication ability of the patient from 0 to 5.
Aphasia Check-list (ACL, 0-148)30-45 mina german tool to assess language (analogous to the Aachener Aphasie Test). it measures a) colour-figure test, b) word generation and c) single speech domains

Secondary

MeasureTime frameDescription
Alterskonzentrationstest (AKT, 0-35)5 minassesses the concentration and vigilance of elderly people with stroke
Rivermead Motor Assessment - Arm (RMA, 0-15)5-10 minassesses the motor control of the upper extremity in patients with stroke
Barthel-Index (BI,0-100)5minevaluates the activities of daily living in patients suffering from stroke
Aphasic depression rating scale (ADRS, 0-32)5 minrates the depression in patients with aphasia

Other

MeasureTime frameDescription
Electroencephalography (EEG)30minto record spontaneous brain activity and to exclude increased cortical excitability

Countries

Germany

Contacts

Primary ContactStefan Hesse, Prof.Dr.
s.hesse@medicalpark.de+49-30-300240
Backup ContactCordula Werner, Dr
cwerner@reha-hesse.de+49-30-300240

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026